A Phase I Study of the Anti-Activin Receptor-Like Kinase 1 (ALK-1) Monoclonal Antibody PF-03446962 in Patients with Advanced Solid Tumors.
Clin Cancer Res
; 22(9): 2146-54, 2016 05 01.
Article
in En
| MEDLINE
| ID: mdl-26655846
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Activin Receptors, Type II
/
Antibodies, Monoclonal
/
Neoplasms
/
Antineoplastic Agents
Type of study:
Clinical_trials
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2016
Document type:
Article
Country of publication: